Ethanesulfonamide,2,2,2-trifluoro-N-[5,6,7,8-tetrahydro-5-(1H-imidazol-4-yl)-1-naphthalenyl]- (258526-55-5)

Identification
Name:	Ethanesulfonamide,2,2,2-trifluoro-N-[5,6,7,8-tetrahydro-5-(1H-imidazol-4-yl)-1-naphthalenyl]-
CAS:	258526-55-5
Molecular Formula:	C₁₅H₁₆F₃N₃O₂S
Molecular Structure:
Properties
Safety Data

Other Product

Ethanesulfonamide,N-[5,6,7,8-tetrahydro-5-(2-methyl-1H-imidazol-4-yl)-1-naphthalenyl]-
Ethanesulfonamide,N-[(5R)-5,6,7,8-tetrahydro-5-(1H-imidazol-4-yl)-1-naphthalenyl]-
Ethanesulfonamide,N-[5,6,7,8-tetrahydro-5-(1H-imidazol-4-yl)-1-naphthalenyl]-
Methanesulfonamide,N-[5,6,7,8-tetrahydro-2-hydroxy-5-(1H-imidazol-4-yl)-1-naphthalenyl]-
Cyclopropanecarboxamide,N-[(8S)-8-[[(3-chloro-4-fluorophenyl)sulfonyl]amino]-5,6,7,8-tetrahydro-2-naphthalenyl]-2-(2-chlorophenyl)-N-[(1-methyl-1H-imidazol-5-yl)methyl]-, (1R,2R)-
Cyclopropanecarboxamide,N-[(8S)-8-[[(3-chloro-4-fluorophenyl)sulfonyl]amino]-5,6,7,8-tetrahydro-2-naphthalenyl]-2-(4-chlorophenyl)-N-[(1-methyl-1H-imidazol-5-yl)methyl]-, (1S,2S)-
Cyclopropanecarboxamide,N-[(8S)-8-[[(3-chloro-4-fluorophenyl)sulfonyl]amino]-5,6,7,8-tetrahydro-2-naphthalenyl]-2-(4-fluorophenyl)-N-[(1-methyl-1H-imidazol-5-yl)methyl]-,(1R,2R)-
Cyclopropanecarboxamide,N-[(8S)-8-[[(3-chloro-4-fluorophenyl)sulfonyl]amino]-5,6,7,8-tetrahydro-2-naphthalenyl]-2-(4-fluorophenyl)-N-[(1-methyl-1H-imidazol-5-yl)methyl]-,(1S,2S)-
Cyclopropanecarboxamide,N-[(8R)-8-[[(3-chloro-4-fluorophenyl)sulfonyl]amino]-5,6,7,8-tetrahydro-2-naphthalenyl]-2-(4-chlorophenyl)-N-[(1-methyl-1H-imidazol-5-yl)methyl]-, (1S,2S)-
Cyclopropanecarboxamide,2-(4-chlorophenyl)-N-[(1-methyl-1H-imidazol-5-yl)methyl]-N-[(8S)-5,6,7,8-tetrahydro-8-[(phenylsulfonyl)amino]-2-naphthalenyl]-, (1S,2S)-
Cyclopropanecarboxamide,2-(4-fluorophenyl)-N-[(1-methyl-1H-imidazol-5-yl)methyl]-N-[(8S)-5,6,7,8-tetrahydro-8-[(phenylsulfonyl)amino]-2-naphthalenyl]-, (1R,2R)-
Cyclopropanecarboxamide,2-(4-fluorophenyl)-N-[(1-methyl-1H-imidazol-5-yl)methyl]-N-[(8S)-5,6,7,8-tetrahydro-8-[(phenylsulfonyl)amino]-2-naphthalenyl]-, (1S,2S)-
Cyclopropanecarboxamide,2-(4-chlorophenyl)-N-[(1-methyl-1H-imidazol-5-yl)methyl]-N-[(8S)-5,6,7,8-tetrahydro-8-[(phenylsulfonyl)amino]-2-naphthalenyl]-, (1R,2R)-
Cyclopropanecarboxamide,2-(4-chlorophenyl)-N-[(1-methyl-1H-imidazol-5-yl)methyl]-N-[(8R)-5,6,7,8-tetrahydro-8-[(phenylsulfonyl)amino]-2-naphthalenyl]-, (1S,2S)-
Benzamide,4-[[7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(3-methylbutyl)-6-oxo-2-pteridinyl]amino]-N-[3-(1H-imidazol-1-yl)propyl]-3-methoxy-
Methanesulfonamide,N-[5-(4,5-dihydro-1H-imidazol-2-yl)-5,6,7,8-tetrahydro-1-naphthalenyl]-
Cyclopropanecarboxamide,2-(2-chlorophenyl)-N-[(1-methyl-1H-imidazol-5-yl)methyl]-N-[(8S)-5,6,7,8-tetrahydro-8-[(phenylsulfonyl)amino]-2-naphthalenyl]-, (1R,2R)-
Ethanesulfonamide,N-[2-chloro-5-(3-chloro-4,5,6,7-tetrahydro-2H-indazol-2-yl)-4-fluorophenyl]-
Ethanesulfonamide, N-[3-(1H-imidazol-4-ylmethyl)-2-methylphenyl]-
Methanesulfonamide,N-[5-(4,5-dihydro-1H-imidazol-2-yl)-5,6,7,8-tetrahydro-2-hydroxy-1-naphthalenyl]-,hydrobromide (1:1)